Long non-coding RNAs in Cancer

Long non-coding RNA (lncRNA) are regulatory RNAs exceeding 200 nucleotides in length. LncRNAs are implicated in regulation of gene transcription, post-transcriptional regulation, as well as epigenetic epigenetic regulation. Here is the latest research on lncRNAs and cancer.

December 8, 2021
Preprint
Open Access

RNA2Immune: A Manually Curated Database of Experimentally Supported Data Linking Noncoding RNA Regulation to the Immune System

BioRxiv : the Preprint Server for Biology
Lihua WangLihua Wang
December 7, 2021

Noncoding RNAs: emerging players in skin cancers pathogenesis.

American Journal of Cancer Research
Lin LiFang Wang
December 7, 2021
Open Access

Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.

Computational and Mathematical Methods in Medicine
Qiaohong NongXue Hu
December 7, 2021
Open Access

Modular signature of long non-coding RNA association networks as a prognostic biomarker in lung cancer.

BMC Medical Genomics
Albert LiHsueh-Fen Juan
December 7, 2021

A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.

Expert Review of Molecular Diagnostics
Tingting CuiZhixia Sun
December 6, 2021
Open Access

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism.

Frontiers in Molecular Biosciences
Hao ZhangXiao Hu
December 6, 2021
Open Access

Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.

Frontiers in Cell and Developmental Biology
Ding LiWenzhou Zhang
December 6, 2021
Review
Open Access

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers.

Frontiers in Cell and Developmental Biology
Chen XueLanjuan Li
December 6, 2021
Open Access

A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer.

Frontiers in Cell and Developmental Biology
Xianwu ChenXiaodong Jin
December 6, 2021
Open Access

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.

Frontiers in Cell and Developmental Biology
Mei ChenShufang Zhang
December 6, 2021
Review
Open Access

Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer.

Frontiers in Cellular and Infection Microbiology
Xueke WangXiwen Jiang
December 6, 2021
Open Access

HOTAIR Modulated Pathways in Early-Stage Breast Cancer Progression.

Frontiers in Oncology
Martin C AbbaC Marcelo Aldaz
December 6, 2021
Open Access

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma.

Frontiers in Oncology
Qinglin FengShibing Fan
December 6, 2021
Review
Open Access

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology.

Frontiers in Oncology
Ashish ManneArjun Mittra

Sign up to follow this feed and discover related papers.

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing studies have shed light on the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). This feed follows papers using RNA sequencing technologies in Alzheimer's research.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

CfDNA Sequencing

Circulating free DNA (cfDNA) are degraded DNA fragments released to the blood plasma. cfDNA has been shown to be a useful biomarker for a multitude of ailments other than cancer and fetal medicine. Here is the latest research on Circulating free DNA (cfDNA) sequencing.

ChIP-Seq

Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) is a genome-wide technique used to map histone marks and protein binding (ie transcription factors) on chromatin. This can reveal insight into the regulation and dynamics of gene expression. Discover the latest research on ChIP-seq here.

© 2021 Meta ULC. All rights reserved
/feed-previews/long-non-coding-rnas-in-cancer/603374c8-43a3-49b2-b548-210c9f0bf5df